SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-121095
Filing Date
2023-11-27
Accepted
2023-11-27 06:37:46
Documents
12
Period of Report
2023-11-22
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2331518d1_8k.htm   iXBRL 8-K 29427
  Complete submission text file 0001104659-23-121095.txt   203213

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA thrx-20231122.xsd EX-101.SCH 3018
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE thrx-20231122_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thrx-20231122_pre.xml EX-101.PRE 22361
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2331518d1_8k_htm.xml XML 3318
Mailing Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142
Business Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Filer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40869 | Film No.: 231437276
SIC: 2834 Pharmaceutical Preparations